Connect your AI

Neuronetics STIM Change in Deferred Revenue

Change in Deferred Revenue at other companies

StereotaxisSTXS

$834K-15.9%

Neuropace, Inc.NPCE

-$15K-112%

ClearPoint NeuroCLPT

$172K+130%

Other financials

Income statement

Revenue$34.5M+7.8%

Gross profit$16.2M+2.6%

Operating income-$9.0M+18.3%

Net income-$10.8M+14.9%

EPS (diluted)-$0.16+23.8%

Balance sheet

Cash & equivalents$13.2M-34.7%

Total debt$85.4M+3.5%

Total equity$13.3M-62.6%

Total assets$125.4M-11.7%

Cash flow

Operating cash flow-$9.4M+44.6%

CapEx$197.0K-10.0%

Free cash flow-$9.6M+44.1%

Valuation

Market cap$90.46M-59.6%

Enterprise value$162.64M-44.6%

P/S0.6×-1.4×

Profitability

Gross margin48%-15.6pp

Operating margin-19.4%-6.9pp

Net margin-24.5%-8.7pp

FCF margin-9.4%-4.1pp

Returns & leverage

Return on equity-152.4%-1.4pp

Debt / equity6.4×+4.1×

Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Neuronetics's change in deferred revenue?: Neuronetics (STIM) reported change in deferred revenue of $90K in Q1 2026.
How has Neuronetics's change in deferred revenue changed year-over-year?: Neuronetics's change in deferred revenue increased by 134.7% year-over-year, from -$259K to $90K.
What is the long-term trend for Neuronetics's change in deferred revenue?: Over 3 years (2021 to 2024), Neuronetics's change in deferred revenue has grown at a 57.7% compound annual growth rate (CAGR), from $215K to -$843K.
What does change in deferred revenue mean?: Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.